Home › Compare › ECPN vs JNJ

ECPN vs JNJ: Dividend Comparison 2026

ECPN yields 500000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ECPN wins by $4.663521010693878e+33M in total portfolio value
10 years
ECPN
ECPN
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full ECPN calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ECPN vs JNJ

📍 ECPN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodECPNJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ECPN + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ECPN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ECPN
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ECPN beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ECPN + JNJ for your $10,000?

ECPN: 50%JNJ: 50%
100% JNJ50/50100% ECPN
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ECPN
No analyst data
Altman Z
-266.8
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ECPN buys
0
JNJ buys
0
No recent congressional trades found for ECPN or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricECPNJNJ
Forward yield500000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$4.663521010693878e+33M$20.0K ✓
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$4.6634009849658873e+33M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ECPN vs JNJ ($10,000, DRIP)

YearECPN PortfolioECPN Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$50,010,700$50,000,000.00$10,676$355.77+$50.00M → ECPN
2$233,748,371,262$233,694,859,813.08$11,407$389.39+$233748.36M → ECPN
3$1,021,074,511,412,696$1,020,824,400,655,446.10$12,198$426.53+$1021074511.40M → ECPN
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$13,056$467.62+$4168597328794.94M → ECPN
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$13,987$513.12+$15905475114600664.00M → ECPN
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$14,998$563.56+$56718938532531060736.00M → ECPN
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$16,098$619.52+$1.8903180743562385e+23M → ECPN
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$17,295$681.69+$5.8879981047651824e+26M → ECPN
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$18,599$750.82+$1.7140642681147225e+30M → ECPN
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$20,022$827.78+$4.663521010693878e+33M → ECPN

ECPN vs JNJ: Complete Analysis 2026

ECPN — Stock

El Capitan Precious Metals, Inc., an exploration stage company, engages in the mining of precious metals and other minerals. The company principally explores for gold, silver, and platinum group metals. Its primary asset is the El Capitan Property comprising 354 Bureau of Land Management lode claims and four patented claims located in Lincoln County, New Mexico. The company was founded in 2002 and is based in Prescott, Arizona.

Full ECPN Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ECPN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ECPN vs SCHDECPN vs JEPIECPN vs OECPN vs KOECPN vs MAINECPN vs ABBVECPN vs MRKECPN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.